Oxygenta Pharmaceutical Ltd — Important, 18-10-2025: Company Update

Oxygenta Pharmaceutical has confirmed its compliance with requirements for dematerialized securities for the latest quarter. The company's Registrar and Transfer Agent certified that all shares received for dematerialization were accurately processed, cancelled, and subsequently updated in the records of depositories like NSDL and CDSL. This swift and accurate processing ensures the integrity of shareholder ownership data for electronically held shares, providing confidence in the company's robust share management practices for investors.